Denemek ALTIN - Özgür
India cuts China bulk-drug reliance
Mint Hyderabad
|March 17, 2025
Bulk drugs accounted for 63% of the total pharmaceutical imports in the country during FY 2018-19
Indian companies have started manufacturing important bulk drugs or active pharmaceutical ingredients (APIs) under the government's production linked incentive (PLI) scheme.
The production of Penicillin G and Clavulanic Acid began in October last year. Other APIs already in production include Atorvastatin, Sulfadiazine, Telmisartan, Olmesartan, Para Amino Phenol (raw material for paracetamol) and Oxcarbazepine.
The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.
These bulk drugs are largely used as antibiotics and to manage non-communicable diseases such as cardiovascular diseases, chronic respiratory diseases, and diabetes.
Bu hikaye Mint Hyderabad dergisinin March 17, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Hyderabad'den DAHA FAZLA HİKAYE
Mint Hyderabad
How low-hanging fruit could give India outsized gains
The Iran conflict has made two things clear: One, a new wave of globalization is coming, like it or not, from which further such shocks can’t be ruled out; and two, dependable dollar inflows from export earnings need to grow handsomely.
3 mins
June 26, 2026
Mint Hyderabad
Careful planning can help India take on its inflation challenges
Rising pressures amid an El Niño-hit monsoon make a case for pre-emptive government measures
3 mins
June 26, 2026
Mint Hyderabad
Air Suvidha back amid Ebola scare
An upgraded version of the air passenger health self-declaration portal Air Suvidha has been launched to enhance public health surveillance amid the Ebola outbreak in certain parts of Africa.
1 min
June 26, 2026
Mint Hyderabad
A pick of films, art and food
A Mint guide to what's happening in and around your city
1 min
June 26, 2026
Mint Hyderabad
Traceability rules cover vaccines, cancer drugs now
The Union health ministry expanded mandatory track-and-trace requirements to cover all vaccines, antibiotics, cancer drugs and narcotic and psychotropic substances, widening an anti-counterfeiting system that previously applied only to India’s 300 top-selling drug brands.
1 min
June 26, 2026
Mint Hyderabad
Regulator cracks down on smuggled, unapproved drugs
DGCI order follows a rise in illegal entry and sale of fake drugs from neighbouring countries
2 mins
June 26, 2026
Mint Hyderabad
As China relations thaw, India set to okay Geely-backed deal
India is set to approve a roughly $370 million investment from Horse Powertrain Ltd, a hybrid-engine venture backed by China’s Zhejiang Geely Holding Group Co., that would mark one of the biggest manufacturing investments from a Chinese-linked company in years.
1 mins
June 26, 2026
Mint Hyderabad
How a crypto exchange became a hub for illicit Iranian cash
Earlier this year, crypto sleuths found an alarming series of transactions tied to two digital wallets controlled by the Central Bank of Iran.
1 mins
June 26, 2026
Mint Hyderabad
India Inc should make queer inclusion an imperative
I grew up in Calcutta in the 2000s. Raised by a single mother, our home was full of activity. My mother carried extraordinary strength into the corporate world.
3 mins
June 26, 2026
Mint Hyderabad
Vedanta's Navin Agarwal bets big on RE magnets
10,000 tonnes in phases, Shukla said. Agarwal's ₹1,250 crore investment will be for the first phase, he added.
1 mins
June 26, 2026
Listen
Translate
Change font size
